Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $1.22 billion. The enterprise value is $1.00 billion.
| Market Cap | 1.22B |
| Enterprise Value | 1.00B |
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 85.15 million shares outstanding. The number of shares has decreased by -3.38% in one year.
| Current Share Class | 85.15M |
| Shares Outstanding | 85.15M |
| Shares Change (YoY) | -3.38% |
| Shares Change (QoQ) | -4.11% |
| Owned by Insiders (%) | 1.23% |
| Owned by Institutions (%) | 92.05% |
| Float | 72.07M |
Valuation Ratios
The trailing PE ratio is 23.92 and the forward PE ratio is 9.16. Progyny's PEG ratio is 1.33.
| PE Ratio | 23.92 |
| Forward PE | 9.16 |
| PS Ratio | 1.17 |
| Forward PS | 1.04 |
| PB Ratio | 2.91 |
| P/TBV Ratio | 2.92 |
| P/FCF Ratio | 7.61 |
| P/OCF Ratio | 7.42 |
| PEG Ratio | 1.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.69, with an EV/FCF ratio of 6.26.
| EV / Earnings | 17.55 |
| EV / Sales | 0.88 |
| EV / EBITDA | 14.69 |
| EV / EBIT | 15.35 |
| EV / FCF | 6.26 |
Financial Position
The company has a current ratio of 2.62, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.62 |
| Quick Ratio | 2.48 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.27 |
| Debt / FCF | 0.12 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.05% and return on invested capital (ROIC) is 8.27%.
| Return on Equity (ROE) | 12.05% |
| Return on Assets (ROA) | 5.90% |
| Return on Capital (ROIC) | 8.27% |
| Revenue Per Employee | $2.01M |
| Profits Per Employee | $101,191 |
| Employee Count | 566 |
| Asset Turnover | 1.64 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $24.53 million in taxes.
| Income Tax | 24.53M |
| Effective Tax Rate | 29.99% |
Stock Price Statistics
The stock price has decreased by -61.22% in the last 52 weeks. The beta is 1.35, so Progyny's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -61.22% |
| 50-Day Moving Average | 15.37 |
| 200-Day Moving Average | 24.40 |
| Relative Strength Index (RSI) | 41.56 |
| Average Volume (20 Days) | 1,667,120 |
Short Selling Information
The latest short interest is 11.41 million, so 13.40% of the outstanding shares have been sold short.
| Short Interest | 11.41M |
| Short Previous Month | 11.42M |
| Short % of Shares Out | 13.40% |
| Short % of Float | 15.83% |
| Short Ratio (days to cover) | 7.21 |
Income Statement
In the last 12 months, Progyny had revenue of $1.14 billion and earned $57.27 million in profits. Earnings per share was $0.60.
| Revenue | 1.14B |
| Gross Profit | 246.83M |
| Operating Income | 65.47M |
| Pretax Income | 84.78M |
| Net Income | 57.27M |
| EBITDA | 68.41M |
| EBIT | 65.47M |
| Earnings Per Share (EPS) | $0.60 |
Balance Sheet
The company has $235.72 million in cash and $19.50 million in debt, giving a net cash position of $216.22 million or $2.54 per share.
| Cash & Cash Equivalents | 235.72M |
| Total Debt | 19.50M |
| Net Cash | 216.22M |
| Net Cash Per Share | $2.54 |
| Equity (Book Value) | 434.88M |
| Book Value Per Share | 4.92 |
| Working Capital | 337.83M |
Cash Flow
In the last 12 months, operating cash flow was $164.60 million and capital expenditures -$4.19 million, giving a free cash flow of $160.41 million.
| Operating Cash Flow | 164.60M |
| Capital Expenditures | -4.19M |
| Free Cash Flow | 160.41M |
| FCF Per Share | $1.88 |
Margins
Gross margin is 21.68%, with operating and profit margins of 5.75% and 5.03%.
| Gross Margin | 21.68% |
| Operating Margin | 5.75% |
| Pretax Margin | 7.18% |
| Profit Margin | 5.03% |
| EBITDA Margin | 6.01% |
| EBIT Margin | 5.75% |
| FCF Margin | 14.09% |
Dividends & Yields
Progyny does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.38% |
| Shareholder Yield | 3.38% |
| Earnings Yield | 4.69% |
| FCF Yield | 13.14% |
Analyst Forecast
The average price target for Progyny is $19.17, which is 33.68% higher than the current price. The consensus rating is "Buy".
| Price Target | $19.17 |
| Price Target Difference | 33.68% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 9.36% |
| EPS Growth Forecast (5Y) | 28.60% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Progyny has an Altman Z-Score of 10.89 and a Piotroski F-Score of 4.
| Altman Z-Score | 10.89 |
| Piotroski F-Score | 4 |